Abstract:Radiotherapy of cancer has been traditionally considered as a local therapy without noticeable effects outside the irradiated fields. However, ionizing radiation exerts multiple biological effects on both malignant and stromal cells that account for a complex spectrum of mechanisms beyond simple termination of cancer cells. In the era of immunotherapy, interest in radiation-induced inflammation and cell death has considerably risen, since these mechanisms lead to profound changes in the systemic immune response against cancer antigens. Immunotherapies such as immunomodulatory monoclonal antibodies (anti-PD-1, anti-CTLA-4, anti-CD137, anti-OX40, anti-CD40, anti-TGFβ), TLR-agonists, and adoptive T-cell therapy have been synergistically combined with radiotherapy in mouse models. Importantly, radiation and immunotherapy combinations do not only act against the irradiated tumor but also against distant non-irradiated metastases (abscopal effects). A series of clinical trials are exploring the beneficial effects of radioimmunotherapy combinations. The concepts of crosspriming of tumor neoantigens and immunogenic cell death are key elements underlying this combination efficacy. Proinflamatory changes in the vasculature of the irradiated lesions and in the cellular composition of the leukocyte infiltrates in the tumor microenvironment contribute to raise or dampen cancer immunogenicity. It should be stressed that not all effects of radiotherapy favor antitumor immunity as there are counterbalancing mechanisms such as TGFβ, and VEGFs that inhibit the efficacy of the antitumor immune response, hence offering additional therapeutic targets to suppress. All in all, radiotherapy and immunotherapy are compatible and often synergistic approaches against cancer that jointly target irradiated and non-irradiated malignant lesions in the same patient.

Research Advances in Radiotherapy Combined with Immunotherapy for Cancer

Radiotherapy-Mediated Immunomodulation and Anti-Tumor Abscopal Effect Combining Immune Checkpoint Blockade

Radiotherapy combined with immunotherapy: the dawn of cancer treatment

Immune modulatory roles of radioimmunotherapy: biological principles and clinical prospects

Recent Research Progress of Abscopal Effect in Tumor Radiotherapy

Abscopal effect: from a rare phenomenon to a new frontier in cancer therapy

Research Advances in Mechanisms for Combination Therapy with Stereotactic Body Radiation Therapy and Immunotherapy

Abscopal effect of radiotherapy combined with immune checkpoint inhibitors

Immune mechanisms mediating abscopal effects in radioimmunotherapy

Challenges in the combination of radiotherapy and immunotherapy for breast cancer

Radiotherapy and Immunotherapy: a Beneficial Liaison?

Combinations of radiotherapy with immunotherapy in cervical cancer

Effective Combinations of Immunotherapy and Radiotherapy for Cancer Treatment

Radiotherapy combined with immunotherapy could improve the immune infiltration of melanoma in mice and enhance the abscopal effect

Radiotherapy combined with nano-biomaterials for cancer radio-immunotherapy

Combining Immunotherapy and Radiotherapy for Cancer Treatment: Current Challenges and Future Directions

Combined use of NK cells and radiotherapy in the treatment of solid tumors

Recent Advances in Engineered Materials for Immunotherapy‐Involved Combination Cancer Therapy

Radiation-induced Tumor Immune Microenvironments and Potential Targets for Combination Therapy

Radiotherapy-activated tumor immune microenvironment: Realizing radiotherapy-immunity combination therapy strategies

The Intersection of Radiotherapy and Immunotherapy: Mechanisms and Clinical Implications.